Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Identifying optimal combinations of symptoms to trigger diagnostic work-up of suspected COVID-19 cases in vaccine trials: analysis from a community-based, prospective, observational cohort

M Antonelli, J Capdevila, A Chaudhari, J Granerod, LS Canas, View ORCID ProfileMS Graham, K Klaser, M Modat, E Molteni, B Murray, View ORCID ProfileC Sudre, R Davies, A May, View ORCID ProfileLH Nguyen, DA Drew, A Joshi, AT Chan, JP Cramer, T Spector, J Wolf, View ORCID ProfileS Ourselin, C Steves, AE Loeliger
doi: https://doi.org/10.1101/2020.11.23.20237313
M Antonelli
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Capdevila
2Zoe Global, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Chaudhari
3Coalition for Epidemic Preparedness Innovations, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Granerod
3Coalition for Epidemic Preparedness Innovations, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LS Canas
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MS Graham
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for MS Graham
K Klaser
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M Modat
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
E Molteni
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
B Murray
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C Sudre
4MRC Unit for Lifelong Health and Ageing at UCL/Centre for Medical Image Computing, Department of Computer Science, UCL, London, UK
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for C Sudre
R Davies
2Zoe Global, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A May
2Zoe Global, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
LH Nguyen
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
6Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for LH Nguyen
DA Drew
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
6Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
A Joshi
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
6Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AT Chan
5Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
6Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JP Cramer
3Coalition for Epidemic Preparedness Innovations, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
T Spector
7Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
J Wolf
2Zoe Global, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S Ourselin
1School of Biomedical Engineering & Imaging Sciences, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for S Ourselin
C Steves
7Department of Twin Research and Genetic Epidemiology, King’s College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Claire.j.steves@kcl.ac.u edde.loeliger@cepi.net
AE Loeliger
3Coalition for Epidemic Preparedness Innovations, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: Claire.j.steves@kcl.ac.u edde.loeliger@cepi.net
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Several COVID-19 vaccine efficacy trials are ongoing with others predicted to start soon. Diagnostic work-up of trial participants following any COVID-19 associated symptom will lead to extensive testing, potentially overwhelming laboratory capacity whilst primarily yielding negative results. We aimed to identify an efficient symptom combination to capture most cases using the lowest possible number of tests.

Methods UK and US users of the COVID-19 Symptom Study app who reported new-onset symptoms between March-September 2020 and an RT-PCR test within seven days of symptom onset were included. Sensitivity, specificity, and number of RT-PCR tests needed to identify one RT-PCR positive case were calculated for individual symptoms and symptom combinations. A multi-objective evolutionary algorithm was applied to generate symptom combinations with good trade-offs between sensitivity and specificity.

Findings The UK dataset included 122,305 individuals (1,202 RT-PCR positive). Findings were replicated in a US dataset including 3,162 individuals (79 RT-PCR positive). Within three days of symptom onset, the COVID-19 specific symptom combination (cough, dyspnoea, fever, anosmia/ageusia) identified 69% of cases requiring 47 RT-PCR tests per positive case. The symptom combination with highest sensitivity was fatigue, anosmia, cough, diarrhoea, headache, and sore throat, identifying 96% of cases and requiring 96 tests.

Interpretation We confirm the significance of COVID-19 specific symptoms widely recommended for triggering RT-PCR. By using the data-driven optimization technique we identified additional symptoms (fatigue, sore throat, headache, diarrhoea) that enabled many more positive cases to be captured efficiently. By providing a set of solutions with optimal trade-offs between sensitivity and specificity, we produced a selection of symptom subsets that maximise the capture of cases given different laboratory capacities. The methodology may be of particular use for COVID-19 vaccine developers across a range of resource settings and have more far-reaching public health implications for detection of symptomatic SARS CoV2 infection.

Funding Zoe Global Limited, Department of Health, Wellcome Trust, Engineering and Physical Sciences Research Council (EPSRC), National Institute for Health Research (NIHR), Medical Research Council (MRC), Alzheimer’s Society, Massachusetts Consortium for Pathogen Readiness (MassCPR), Coalition for Epidemic Preparedness Innovations (CEPI)

Evidence before this study We searched PubMed up to November 16, 2020, with the terms “COVID-19” OR “SARS-CoV-2” AND “symptom” AND “community-based”, with no date or language restrictions, to find information about symptoms associated with COVID-19 from the community setting. The search retrieved 68 articles; however, most were not relevant as related to specific subgroups (e.g. pregnant women, cancer patients) or aspects (e.g. mental health, diagnostic testing). Fever, cough, dyspnoea, tachypnoea, anosmia, and ageusia are the symptoms most commonly identified in COVID-19 patients and typically included in guidelines from the WHO and similar bodies. These data however come primarily from hospital-based studies. An assessment of the value of symptom combinations in the community in predicting COVID-19 is lacking.

Added value of this study We present data from the largest, prospective community-based cohort study to date and quantify the contribution of various COVID-19 symptoms and symptom-combinations to RT-PCR positive COVID-19 case-finding. Our study is unique in that it simulates PCR testing in a clinical trial situation. Newly-symptomatic individuals were investigated at three days of symptom onset, and a second analysis of symptoms that occurred within seven days of symptom onset was also included to capture delayed symptom triggers. We confirm the significance of symptoms (e.g. fever, cough, anosmia/ageusia) widely used for triggering a RT-PCR test and identified additional symptoms such as fatigue, headache, sore throat, and diarrhoea to define the most efficient symptom combinations.

Implications of all the available evidence The applied methodology enables the selection of symptom subsets to maximise the capture of cases while taking account of specific laboratory capacity. Our findings have important implications for COVID-19 vaccine developers to optimise the choice of triggering symptoms for diagnostic work-up COVID-19 vaccine efficacy trials and also implications for public health due to the community-based nature of the data source used.

Competing Interest Statement

JW, RD, JCP, AM are employees of Zoe Global Ltd. ATC reports grants from Massachusetts Consortium on Pathogen Readiness, during the conduct of the study; personal fees from Pfizer Inc., grants and personal fees from Bayer Pharma; CEPI (authors AC, JG, JPC, AEL) funds clinical trials of COVID-19 vaccines. All other authors declare no competing interests.

Funding Statement

Zoe Global Limited, Department of Health, Wellcome Trust, Engineering and Physical Sciences Research Council (EPSRC), National Institute for Health Research (NIHR), Medical Research Council (MRC), Alzheimer's Society, Massachusetts Consortium for Pathogen Readiness (MassCPR), Coalition for Epidemic Preparedness Innovations (CEPI)

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Ethics has been approved by KCL Ethics Committee REMAS ID 18210, review reference LRS-19/20-18210 and all participants provided consent.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data collected in the COVID-19 Symptom Study smartphone application are being shared with other health researchers through the UK National Health Service-funded Health Data Research UK (HDRUK) and Secure Anonymised Information Linkage consortium housed in the UK Secure Research Platform (Swansea, UK). Anonymised data are available to be shared with HDRUK researchers according to their protocols in the public interest (https://web.www.healthdatagateway.org/dataset/fddcb382-3051-4394-8436-b92295f14259). US investigators are encouraged to coordinate data requests through the Coronavirus Pandemic Epidemiology Consortium (https://www.monganinstitute.org/cope-consortium).

https://web.www.healthdatagateway.org/dataset/fddcb382-3051-4394-8436-b92295f14259

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted November 25, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Identifying optimal combinations of symptoms to trigger diagnostic work-up of suspected COVID-19 cases in vaccine trials: analysis from a community-based, prospective, observational cohort
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Identifying optimal combinations of symptoms to trigger diagnostic work-up of suspected COVID-19 cases in vaccine trials: analysis from a community-based, prospective, observational cohort
M Antonelli, J Capdevila, A Chaudhari, J Granerod, LS Canas, MS Graham, K Klaser, M Modat, E Molteni, B Murray, C Sudre, R Davies, A May, LH Nguyen, DA Drew, A Joshi, AT Chan, JP Cramer, T Spector, J Wolf, S Ourselin, C Steves, AE Loeliger
medRxiv 2020.11.23.20237313; doi: https://doi.org/10.1101/2020.11.23.20237313
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Identifying optimal combinations of symptoms to trigger diagnostic work-up of suspected COVID-19 cases in vaccine trials: analysis from a community-based, prospective, observational cohort
M Antonelli, J Capdevila, A Chaudhari, J Granerod, LS Canas, MS Graham, K Klaser, M Modat, E Molteni, B Murray, C Sudre, R Davies, A May, LH Nguyen, DA Drew, A Joshi, AT Chan, JP Cramer, T Spector, J Wolf, S Ourselin, C Steves, AE Loeliger
medRxiv 2020.11.23.20237313; doi: https://doi.org/10.1101/2020.11.23.20237313

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Informatics
Subject Areas
All Articles
  • Addiction Medicine (228)
  • Allergy and Immunology (506)
  • Anesthesia (110)
  • Cardiovascular Medicine (1245)
  • Dentistry and Oral Medicine (206)
  • Dermatology (147)
  • Emergency Medicine (282)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (534)
  • Epidemiology (10032)
  • Forensic Medicine (5)
  • Gastroenterology (500)
  • Genetic and Genomic Medicine (2465)
  • Geriatric Medicine (238)
  • Health Economics (480)
  • Health Informatics (1647)
  • Health Policy (754)
  • Health Systems and Quality Improvement (637)
  • Hematology (250)
  • HIV/AIDS (536)
  • Infectious Diseases (except HIV/AIDS) (11872)
  • Intensive Care and Critical Care Medicine (626)
  • Medical Education (253)
  • Medical Ethics (75)
  • Nephrology (268)
  • Neurology (2290)
  • Nursing (139)
  • Nutrition (352)
  • Obstetrics and Gynecology (454)
  • Occupational and Environmental Health (537)
  • Oncology (1249)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (325)
  • Pediatrics (734)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2281)
  • Public and Global Health (4844)
  • Radiology and Imaging (843)
  • Rehabilitation Medicine and Physical Therapy (492)
  • Respiratory Medicine (652)
  • Rheumatology (286)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (227)
  • Surgery (269)
  • Toxicology (44)
  • Transplantation (125)
  • Urology (99)